Calumet, Inc.
US ˙ NasdaqGS ˙ US1314761032

SecurityCLMT / Calumet, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership169,490 shares
Latest Disclosed Value $ 3,367,767
Barclays Plc reports 74.40% increase in ownership of CLMT / Calumet, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 169,490 shares of Calumet, Inc. (US:CLMT) valued at $3,367,766 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 97,186 shares of Calumet, Inc.. This represents a change in shares of 74.40% during the quarter. The current value of the position is $6,333,841 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CALUMET COM 131428104 169,490 72,304 74.40 3,368 89.90 0.0008
2026-03-31 2025-09-30 13F/A-3 CALUMET COM 131428104 97,186 -51,835 -34.78 1,774 -24.46 0.0004
2026-03-19 2025-09-30 13F/A-2 CALUMET COM 131428104 35,645 -113,376 635 0.0002
2025-11-12 2025-09-30 13F CALUMET COM 131428104 97,186 -51,835 1,774 0.0004
2026-02-27 2025-06-30 13F/A-2 CALUMET COM 131428104 149,021 59,642 66.73 2,348 107.15 0.0005
2025-08-14 2025-06-30 13F/A-1 CALUMET COM 131428104 149,021 59,642 2 0.0005
2025-08-13 2025-06-30 13F CALUMET COM 131428104 149,021 59,642 2 0.0002
2026-03-17 2025-03-31 13F/A-1 CALUMET COM 131428104 89,379 -5,574 -5.87 1,133 -45.79 0.0003
2025-05-15 2025-03-31 13F CALUMET COM 131428104 89,379 -5,574 1 0.0003
2026-03-19 2024-12-31 13F/A-1 CALUMET COM 131428104 94,953 59,308 166.39 2,091 229.13 0.0006
2025-02-13 2024-12-31 13F CALUMET COM 131428104 94,953 59,308 2 0.0006
2026-03-31 2024-09-30 13F/A-2 CALUMET COM 131428104 35,645 35,645 635 0.0002
2024-11-19 2024-09-30 13F/A-1 CALUMET COM 131428104 35,645 35,645 1 0.0002
2024-11-15 2024-09-30 13F CALUMET COM 131428104 35,645 35,645 1 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.